Natriuretic peptides, such as atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), are ... has been hypothesized to counterbalance the vasoconstrictive and pro-fibrotic impacts of ...

Background The role of cyclic guanosine 3′,5′-monophosphate (cGMP) after acute myocardial infarction (AMI) is not well understood despite its significance as a second messenger of natriuretic peptides ...

22 However, it is important to note that natriuretic peptide levels may be either falsely elevated in specific conditions, such as renal impairment or atrial fibrillation, or inappropriately low ...

We developed a novel peptide, NPA7, that coactivates the GC-A (guanylyl cyclase A)/cGMP and MasR (Mas receptor)/cAMP pathway. This study aimed to test NPA7’s ability to inhibit oxidative stress by ...

However, despite the advances in the field and the identification of numerous potential candidates, their implementation in clinical practice beyond natriuretic peptides and troponins is mostly ...

Reid, hereinafter “PeptiDream”) (Tokyo:4587) today announced its second wholly-owned peptide radiopharmaceutical development candidate arising from the company’s ongoing internal peptide ...

Blood samples for B-type natriuretic peptide and norepinephrine measurements were obtained immediately before ... CTI in patients with HF has been suggested to be associated with downregulation of ...